| Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice Y Shizukuda, S Matoba, OY Mian, T Nguyen, PM Hwang Molecular and cellular biochemistry 273, 25-32, 2005 | 159 | 2005 |
| NCCN Guidelines® insights: bladder cancer, version 2.2022: featured updates to the NCCN guidelines TW Flaig, PE Spiess, M Abern, N Agarwal, R Bangs, SA Boorjian, ... Journal of the National Comprehensive Cancer Network 20 (8), 866-878, 2022 | 138 | 2022 |
| Circulating transcriptome reveals markers of atherosclerosis WD Patino, OY Mian, JG Kang, S Matoba, LD Bartlett, B Holbrook, ... Proceedings of the National Academy of Sciences 102 (9), 3423-3428, 2005 | 110 | 2005 |
| Molecular characterization of neuroendocrine-like bladder cancer J Batista da Costa, EA Gibb, TJ Bivalacqua, Y Liu, HZ Oo, DT Miyamoto, ... Clinical cancer research 25 (13), 3908-3920, 2019 | 84 | 2019 |
| Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures R Vander Velde, N Yoon, V Marusyk, A Durmaz, A Dhawan, ... Nature communications 11 (1), 2393, 2020 | 82 | 2020 |
| Serial analysis of gene expression: technical considerations and applications to cardiovascular biology WD Patino, OY Mian, PM Hwang Circulation research 91 (7), 565-569, 2002 | 78 | 2002 |
| Atherosclerotic plaque macrophage transcriptional regulators are expressed in blood and modulated by tristetraprolin WD Patino, JG Kang, S Matoba, OY Mian, BR Gochuico, PM Hwang Circulation research 98 (10), 1282-1289, 2006 | 61 | 2006 |
| GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stress OY Mian, MH Khattab, M Hedayati, J Coulter, B Abubaker‐Sharif, ... The Prostate 76 (2), 199-206, 2016 | 57 | 2016 |
| Methyl-binding domain protein 2–dependent proliferation and survival of breast cancer cells OY Mian, SZ Wang, SZ Zhu, MN Gnanapragasam, L Graham, HD Bear, ... Molecular Cancer Research 9 (8), 1152-1162, 2011 | 55 | 2011 |
| Transcriptomic and protein analysis of small-cell bladder cancer (SCBC) identifies prognostic biomarkers and DLL3 as a relevant therapeutic target VS Koshkin, JA Garcia, J Reynolds, P Elson, C Magi-Galluzzi, ... Clinical Cancer Research 25 (1), 210-221, 2019 | 54 | 2019 |
| A Therapeutic Strategy for Preferential Targeting of TET2-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms Y Guan, AD Tiwari, JG Phillips, M Hasipek, DR Grabowski, S Pagliuca, ... Blood cancer discovery 2 (2), 146-161, 2021 | 45 | 2021 |
| Patients with muscle-invasive bladder cancer with nonluminal subtype derive greatest benefit from platinum based neoadjuvant chemotherapy Y Lotan, JJ De Jong, VYT Liu, TA Bismar, SA Boorjian, HC Huang, ... The Journal of Urology 207 (3), 541-550, 2022 | 39 | 2022 |
| The role of the epigenetic signal, DNA methylation, in gene regulation during erythroid development GD Ginder, MN Gnanapragasam, OY Mian Current topics in developmental biology 82, 85-116, 2008 | 39 | 2008 |
| Androgen deprivation followed by acute androgen stimulation selectively sensitizes AR-positive prostate cancer cells to ionizing radiation M Hedayati, MC Haffner, JB Coulter, RR Raval, Y Zhang, H Zhou, O Mian, ... Clinical Cancer Research 22 (13), 3310-3319, 2016 | 37 | 2016 |
| Management options in locally advanced pancreatic cancer OY Mian, AN Ram, R Tuli, JM Herman Current oncology reports 16, 1-12, 2014 | 36 | 2014 |
| Impact of cribriform pattern and intraductal carcinoma on Gleason 7 prostate cancer treated with external beam radiotherapy MC Tom, JK Nguyen, R Lucianò, OY Mian, KL Stephans, JP Ciezki, ... The Journal of Urology 202 (4), 710-716, 2019 | 35 | 2019 |
| Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings AS Purysko, C Magi-Galluzzi, OY Mian, S Sittenfeld, E Davicioni, ... European radiology 29, 4861-4870, 2019 | 35 | 2019 |
| Ten-year outcomes of moderately hypofractionated (70 Gy in 28 fractions) intensity modulated radiation therapy for localized prostate cancer I Abu-Gheida, CA Reddy, R Kotecha, MA Weller, C Shah, PA Kupelian, ... International Journal of Radiation Oncology* Biology* Physics 104 (2), 325-333, 2019 | 28 | 2019 |
| Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response R Vargas, P Gopal, GB Kuzmishin, R DeBernardo, SA Koyfman, BK Jha, ... NPJ Precision Oncology 2 (1), 14, 2018 | 25 | 2018 |
| Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy P Grivas, TA Bismar, AS Alva, HC Huang, Y Liu, R Seiler, N Alimohamed, ... Urologic Oncology: Seminars and Original Investigations 38 (4), 262-268, 2020 | 24 | 2020 |
Eric A. KleinChairman, Glickman Urological and Kidney Institute, Cleveland ClinicVerified email at ccf.org
